From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.05
First Reported 2006
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0
Pain Relevance 1.11

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (ADORA2A) enzyme binding (ADORA2A) cell-cell signaling (ADORA2A)
signal transducer activity (ADORA2A)
ADORA2A (Homo sapiens)
Pain Link Frequency Relevance Heat
adenocard 67 100.00 Very High Very High Very High
antagonist 24 99.98 Very High Very High Very High
Potency 3 87.68 High High
agonist 29 79.12 Quite High
imagery 13 44.88 Quite Low
Pain 1 39.60 Quite Low
Inflammation 5 36.44 Quite Low
analgesia 1 11.44 Low Low
Opioid 1 11.04 Low Low
Analgesic 1 5.20 Low Low
Disease Link Frequency Relevance Heat
Pain 1 39.60 Quite Low
Cv Unclassified Under Development 5 39.24 Quite Low
Injury 1 38.80 Quite Low
Cancer 2 37.92 Quite Low
Asthma 5 37.60 Quite Low
INFLAMMATION 5 36.44 Quite Low
Stress 7 32.12 Quite Low
Breast Cancer 1 31.64 Quite Low
Increased Venous Pressure Under Development 20 8.56 Low Low
Nociception 2 7.60 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
g as coronary vasodilators, and further SAR investigation suggested that an extended presentation of the 4-substituted pyrazole would be preferred for selective binding at the A2A receptor (Palle et al 2000).
A2A receptor Binding (binding) of
1) Confidence 0.05 Published 2008 Journal Vascular Health and Risk Management Section Body Doc Link PMC2496979 Disease Relevance 0 Pain Relevance 0.49
Novel antagonist radioligands to A2B adenosine subtype
adenosine subtype Binding (radioligands) of associated with adenocard and antagonist
2) Confidence 0.04 Published 2006 Journal Purinergic Signal Section Body Doc Link PMC2096665 Disease Relevance 0 Pain Relevance 0.62

General Comments

This test has worked.

Personal tools